Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women
2019 · Science China Life Sciences · 51 citations
https://doi.org/10.1007/s11427-019-9547-7
X
Xiànghóng Wú
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
115
Papers
2.6K
Citations
29
h-index
64
i10-index
Xiànghóng Wú is an academic researcher from Guangxi Medical University. The author has contributed to research in topics: Phase Equilibria and Thermodynamics & Synthesis and Biological Evaluation & Rheology and Fluid Dynamics Studies. The author has an h-index of 29, co-authored 98 publications.
Papers by this author
worksSafety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials
2021 · Signal Transduction and Targeted Therapy · 36 citations
https://doi.org/10.1038/s41392-021-00692-3
Long-Term immunopersistence and safety of the <i>Escherichia coli</i> -produced HPV-16/18 bivalent vaccine in Chinese adolescent girls
2022 · Human Vaccines & Immunotherapeutics · 6 citations
https://doi.org/10.1080/21645515.2022.2061248
The application and effect of predictive nursing in the prevention of accidental events during operations for SMI patients
2023 · Archives of Psychiatric Nursing · 0 citations
https://doi.org/10.1016/j.apnu.2023.08.001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat